Q3 2025 13F Holders as of 30 Sep 2025
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
26.5M
-
Number of holders
-
74
-
Total 13F shares, excl. options
-
5.11M
-
Shares change
-
-2.57M
-
Total reported value, excl. options
-
$26.1M
-
Value change
-
-$13.3M
-
Put/Call ratio
-
0.25
-
Number of buys
-
26
-
Number of sells
-
-55
-
Price
-
$5.11
Significant Holders of AVITA Medical, Inc. - Common Stock (RCEL) as of Q3 2025
99 filings reported holding RCEL - AVITA Medical, Inc. - Common Stock as of Q3 2025.
AVITA Medical, Inc. - Common Stock (RCEL) has 74 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 5.11M shares
of 26.5M outstanding shares and own 19.32% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (1.37M shares), BlackRock, Inc. (1.14M shares), STATE STREET CORP (423K shares), GEODE CAPITAL MANAGEMENT, LLC (331K shares), NORTHERN TRUST CORP (173K shares), MILLENNIUM MANAGEMENT LLC (133K shares), AQR CAPITAL MANAGEMENT LLC (119K shares), BRIDGEWAY CAPITAL MANAGEMENT, LLC (118K shares), GOLDMAN SACHS GROUP INC (117K shares), and Divisadero Street Capital Management, LP (100K shares).
This table shows the top 74 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.